Literature DB >> 10688662

The branch point enzyme of the mevalonate pathway for protein prenylation is overexpressed in the ob/ob mouse and induced by adipogenesis.

D Vicent1, E Maratos-Flier, C R Kahn.   

Abstract

We have recently reported that skeletal muscle of the ob/ob mouse, an animal model of genetic obesity with extreme insulin resistance, exhibits alterations in the expression of multiple genes. Analysis and cloning of a full-length cDNA of one of the overexpressed mRNAs revealed a 300-amino-acid protein that could be identified as the mouse geranylgeranyl diphosphate synthase (GGPP synthase) based on its homology to proteins cloned from yeast and fungus. GGPP synthase catalyzes the synthesis of all-trans-geranylgeranyl diphosphate (GGPP), an isoprenoid used for protein isoprenylation in animal cells, and is a branch point enzyme in the mevalonic acid pathway. Three mRNAs for GGPP synthase of 4.3, 3.2, and 1.7 kb were detected in Northern blot analysis. Western blot analysis of tissue homogenates using specific antipeptide antibodies revealed a single band of 34.8 kDa. Expression level of this protein in different tissues correlated with expression of the 4.3- and 3.2-kb mRNAs. GGPP synthase mRNA expression was increased 5- to 20-fold in skeletal muscle, liver, and fat of ob/ob mice by Northern blot analysis. Western blot analysis also showed a twofold overexpression of the protein in muscle and fat but not in liver, where the dominant isoform is encoded by the 1.7-kb mRNA. Differentiation of 3T3-L1 fibroblasts into adipocytes induced GGPP synthase expression more than 20-fold. Using the immunoprecipitated protein, we found that mammalian GGPP synthase synthesizes not only GGPP but also its metabolic precursor farnesyl diphosphate. Thus, the expression of GGPP synthase is regulated in multiple tissues in obesity and is induced during adipocyte differentiation. Altered regulation in the synthesis of isoprenoids for protein prenylation in obesity might be a factor determining the ability of the cells to respond to hormonal stimulation requiring both Ras-related small GTPases and trimeric G protein-coupled receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10688662      PMCID: PMC110832          DOI: 10.1128/MCB.20.6.2158-2166.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  39 in total

Review 1.  Protein isoprenylation and methylation at carboxyl-terminal cysteine residues.

Authors:  S Clarke
Journal:  Annu Rev Biochem       Date:  1992       Impact factor: 23.643

2.  Molecular cloning and sequence of a cholesterol-repressible enzyme related to prenyltransferase in the isoprene biosynthetic pathway.

Authors:  C F Clarke; R D Tanaka; K Svenson; M Wamsley; A M Fogelman; P A Edwards
Journal:  Mol Cell Biol       Date:  1987-09       Impact factor: 4.272

3.  Identification of the GGPS1 genes encoding geranylgeranyl diphosphate synthases from mouse and human.

Authors:  T Kainou; K Kawamura; K Tanaka; H Matsuda; M Kawamukai
Journal:  Biochim Biophys Acta       Date:  1999-03-25

4.  Human geranylgeranyl diphosphate synthase. cDNA cloning and expression.

Authors:  T Kuzuguchi; Y Morita; I Sagami; H Sagami; K Ogura
Journal:  J Biol Chem       Date:  1999-02-26       Impact factor: 5.157

5.  Effect of insulin on farnesyltransferase. Specificity of insulin action and potentiation of nuclear effects of insulin-like growth factor-1, epidermal growth factor, and platelet-derived growth factor.

Authors:  M L Goalstone; J W Leitner; K Wall; L Dolgonos; K I Rother; D Accili; B Draznin
Journal:  J Biol Chem       Date:  1998-09-11       Impact factor: 5.157

6.  Human geranylgeranyl diphosphate synthase: isolation of the cDNA, chromosomal mapping and tissue expression.

Authors:  J Ericsson; J M Greene; K C Carter; B K Shell; D R Duan; C Florence; P A Edwards
Journal:  J Lipid Res       Date:  1998-09       Impact factor: 5.922

7.  Human lamin B contains a farnesylated cysteine residue.

Authors:  C C Farnsworth; S L Wolda; M H Gelb; J A Glomset
Journal:  J Biol Chem       Date:  1989-12-05       Impact factor: 5.157

8.  A pathway where polyprenyl diphosphate elongates in prenyltransferase. Insight into a common mechanism of chain length determination of prenyltransferases.

Authors:  S Ohnuma; K Hirooka; N Tsuruoka; M Yano; C Ohto; H Nakane; T Nishino
Journal:  J Biol Chem       Date:  1998-10-09       Impact factor: 5.157

9.  Molecular cloning of a Neurospora crassa carotenoid biosynthetic gene (albino-3) regulated by blue light and the products of the white collar genes.

Authors:  M A Nelson; G Morelli; A Carattoli; N Romano; G Macino
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

10.  Insulin promotes phosphorylation and activation of geranylgeranyltransferase II. Studies with geranylgeranylation of rab-3 and rab-4.

Authors:  M L Goalstone; J W Leitner; I Golovchenko; M R Stjernholm; M Cormont; Y Le Marchand-Brustel; B Draznin
Journal:  J Biol Chem       Date:  1999-01-29       Impact factor: 5.157

View more
  11 in total

1.  Gene expression profiling reveals a diverse array of pathways inhibited by nuclear receptor SHP during adipogenesis.

Authors:  Guisheng Song; Kyungtae Park; Li Wang
Journal:  Int J Clin Exp Pathol       Date:  2008-11-03

Review 2.  The balance of protein farnesylation and geranylgeranylation during the progression of nonalcoholic fatty liver disease.

Authors:  Yue Zhao; Tian-Yu Wu; Meng-Fei Zhao; Chao-Jun Li
Journal:  J Biol Chem       Date:  2020-03-05       Impact factor: 5.157

3.  Lipid-induced Muscle Insulin Resistance Is Mediated by GGPPS via Modulation of the RhoA/Rho Kinase Signaling Pathway.

Authors:  Weiwei Tao; Jing Wu; Bing-Xian Xie; Yuan-Yuan Zhao; Ning Shen; Shan Jiang; Xiu-Xing Wang; Na Xu; Chen Jiang; Shuai Chen; Xiang Gao; Bin Xue; Chao-Jun Li
Journal:  J Biol Chem       Date:  2015-06-25       Impact factor: 5.157

Review 4.  Cofilin-mediated neurodegeneration in Alzheimer's disease and other amyloidopathies.

Authors:  Michael T Maloney; James R Bamburg
Journal:  Mol Neurobiol       Date:  2007-02       Impact factor: 5.590

5.  Trans, trans-farnesol as a mevalonate-derived inducer of murine 3T3-F442A pre-adipocyte differentiation.

Authors:  Sheida Torabi; Huanbiao Mo
Journal:  Exp Biol Med (Maywood)       Date:  2015-12-08

6.  In vivo evaluation of combination therapy targeting the isoprenoid biosynthetic pathway.

Authors:  Staci L Haney; Michelle L Varney; Yashpal Chhonker; Geoffrey Talmon; Lynette M Smith; Daryl J Murry; Sarah A Holstein
Journal:  Pharmacol Res       Date:  2021-03-03       Impact factor: 7.658

7.  GGPPS1 predicts the biological character of hepatocellular carcinoma in patients with cirrhosis.

Authors:  De-cai Yu; Jia Liu; Jun Chen; Jiao-jiao Shao; Xiao Shen; Hong-guang Xia; Chao-jun Li; Bin Xue; Yi-tao Ding
Journal:  BMC Cancer       Date:  2014-04-09       Impact factor: 4.430

Review 8.  Role of G-proteins in islet function in health and diabetes.

Authors:  Anjaneyulu Kowluru
Journal:  Diabetes Obes Metab       Date:  2017-09       Impact factor: 6.577

9.  Increased Expression of RhoA in Epithelium and Smooth Muscle of Obese Mouse Models: Implications for Isoprenoid Control of Airway Smooth Muscle and Fibroblasts.

Authors:  Kristie R Ross; Rebecca J Darrah; Craig A Hodges; Latresa Lang; Thomas J Kelley
Journal:  J Allergy (Cairo)       Date:  2013-06-11

10.  Alteration of mevalonate pathway in proliferated vascular smooth muscle from diabetic mice: possible role in high-glucose-induced atherogenic process.

Authors:  Guo-Ping Chen; Xiao-Qin Zhang; Tao Wu; Liang Li; Jie Han; Chang-Qing Du
Journal:  J Diabetes Res       Date:  2015-03-30       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.